Rad23 links DNA repair to the ubiquitin/proteasome pathway C Schauber, L Chen, P Tongaonkar, I Vega, D Lambertson, W Potts, ... Nature 391 (6668), 715-718, 1998 | 593 | 1998 |
The exocyst complex associates with microtubules to mediate vesicle targeting and neurite outgrowth IE Vega, SC Hsu Journal of Neuroscience 21 (11), 3839-3848, 2001 | 288 | 2001 |
Biomarkers for the early detection and progression of Alzheimer's disease SE Counts, MD Ikonomovic, N Mercado, IE Vega, EJ Mufson Neurotherapeutics 14 (1), 35-53, 2017 | 199 | 2017 |
Barnacle cement: a polymerization model based on evolutionary concepts GH Dickinson, IE Vega, KJ Wahl, B Orihuela, V Beyley, EN Rodriguez, ... Journal of Experimental Biology 212 (21), 3499-3510, 2009 | 160 | 2009 |
Alzheimer’s disease in the Latino community: intersection of genetics and social determinants of health IE Vega, LY Cabrera, CM Wygant, D Velez-Ortiz, SE Counts Journal of Alzheimer's disease 58 (4), 979-992, 2017 | 112 | 2017 |
The septin protein Nedd5 associates with both the exocyst complex and microtubules and disruption of its GTPase activity promotes aberrant neurite sprouting in PC12 cells IE Vega, SC Hsu Neuroreport 14 (1), 31-37, 2003 | 109 | 2003 |
Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center MG Livney, CM Clark, JH Karlawish, S Cartmell, M Negrón, J Nuñez, ... The American Journal of Geriatric Psychiatry 19 (5), 430-439, 2011 | 100 | 2011 |
Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates IE Vega, L Cui, JA Propst, ML Hutton, G Lee, SH Yen Molecular brain research 138 (2), 135-144, 2005 | 94 | 2005 |
Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004 K Steenland, J MacNeil, I Vega, A Levey Alzheimer Disease & Associated Disorders 23 (2), 165-170, 2009 | 80 | 2009 |
A novel calcium‐binding protein is associated with tau proteins in tauopathy IE Vega, EE Traverso, Y Ferrer‐Acosta, E Matos, M Colon, J Gonzalez, ... Journal of neurochemistry 106 (1), 96-106, 2008 | 79 | 2008 |
Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson’s disease P Li, BA Killinger, E Ensink, I Beddows, A Yilmaz, N Lubben, J Lamp, ... Metabolites 11 (1), 29, 2021 | 77 | 2021 |
Synthesis of acid-cleavable light isotope-coded affinity tags (ICAT-L) for potential use in proteomic expression profiling analysis AH Fauq, R Kache, MA Khan, IE Vega Bioconjugate chemistry 17 (1), 248-254, 2006 | 57 | 2006 |
Structure of an AMPK complex in an inactive, ATP-bound state Y Yan, S Mukherjee, KG Harikumar, TS Strutzenberg, XE Zhou, ... Science 373 (6553), 413-419, 2021 | 49 | 2021 |
EF hd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease Y Ferrer‐Acosta, EN Rodríguez‐Cruz, F Orange, H De Jesús‐Cortés, ... Journal of neurochemistry 125 (6), 921-931, 2013 | 47 | 2013 |
Hemispheric asymmetry in the human brain and in Parkinson’s disease is linked to divergent epigenetic patterns in neurons P Li, E Ensink, S Lang, L Marshall, M Schilthuis, J Lamp, I Vega, V Labrie Genome biology 21, 1-23, 2020 | 43 | 2020 |
Oxidative stress in neurodegenerative disease: causation or association? JM Van Raamsdonk, IE Vega, P Brundin Oncotarget 8 (7), 10777, 2017 | 39 | 2017 |
Identification and functional analysis of novel phosphorylation sites in the RNA surveillance protein Upf1 C Lasalde, AV Rivera, AJ Leon, JA Gonzalez-Feliciano, LA Estrella, ... Nucleic acids research 42 (3), 1916-1929, 2014 | 37 | 2014 |
EFhd2, a protein linked to Alzheimer's disease and other neurological disorders IE Vega Frontiers in neuroscience 10, 186501, 2016 | 35 | 2016 |
EFhd2 affects tau liquid–liquid phase separation IE Vega, A Umstead, NM Kanaan Frontiers in neuroscience 13, 476095, 2019 | 29 | 2019 |
Functional and structural analysis of the conserved EFhd2 protein Y Ferrer-Acosta, E N Rodriguez Cruz, A del C Vaquer, I E Vega Protein and peptide letters 20 (5), 573-583, 2013 | 29 | 2013 |